Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor Cancer × Cisplatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 450 Squamous Cell Carcinoma of Head and Neck 212 Lung Neoplasms 203 Head and Neck Neoplasms 203 Uterine Cervical Neoplasms 139 Esophageal Neoplasms 137 Stomach Neoplasms 135 Nasopharyngeal Carcinoma 113 Urinary Bladder Neoplasms 96 Neoplasms 92 Esophageal Squamous Cell Carcinoma 91 Small Cell Lung Carcinoma 83 Breast Neoplasms 79 Ovarian Neoplasms 72 Neoplasm Metastasis 69 Pancreatic Neoplasms 65 Cholangiocarcinoma 62 Carcinoma, Squamous Cell 62 Biliary Tract Neoplasms 60 Mesothelioma, Malignant 52 Adenocarcinoma Of Esophagus 44 Carcinoma 43 Recurrence 40 Oropharyngeal Neoplasms 40 Carcinoma, Ovarian Epithelial 40 Parkinson Disease 4, Autosomal Dominant Lewy Body 39 Gallbladder Neoplasms 35 Adenocarcinoma of Lung 35 Lymphoma 33 Melanoma 31

Interventions

ispinesib 2 trametinib 1 irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡